[Table/Fig-7]:
Antibiotics | Staphylococcus aureus n=7) | CONS (n=2) |
---|---|---|
PEN | 7 (100%) | 2(100%) |
AMC | 6 (85.71%) | 0 |
CXN | 6 (85.71%) | 1 (50%) |
ERY | 5(71.43%) | 1 (50%) |
CLD | 3 (42.86%) | 0 |
LZD | 0 | 0 |
VAN | 0 | 0 |
Antibiotics | Staphylococcus aureus n=7) | CONS (n=2) |
---|---|---|
PEN | 7 (100%) | 2(100%) |
AMC | 6 (85.71%) | 0 |
CXN | 6 (85.71%) | 1 (50%) |
ERY | 5(71.43%) | 1 (50%) |
CLD | 3 (42.86%) | 0 |
LZD | 0 | 0 |
VAN | 0 | 0 |